Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate

被引:87
作者
Blande, Ivan Souza [1 ]
Bassaneze, Vinicius [1 ]
Lavini-Ramos, Carolina [1 ]
Fae, Kellen Cristhina [1 ]
Kalil, Jorge [1 ]
Miyakawa, Ayumi Aurea [1 ]
Schettert, Isolmar Tadeu [1 ]
Krieger, Jose Eduardo [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol LIM 13, BR-05403000 Sao Paulo, Brazil
关键词
IN-VITRO EXPANSION; FETAL CALF SERUM; STROMAL CELLS; THERAPY; FISTULA; DIFFERENTIATION; TRANSPLANTATION; DISEASE; SAFETY;
D O I
10.1111/j.1537-2995.2009.02346.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND: Mesenchymal stem cells (MSCs) have been considered for human regenerative therapy applications, and safe culture and expansion protocols are needed especially in the context of interspecies contamination. Human platelet lysate (PL) has been proposed as animal serum substitute during in vitro MSC expansion. In this work, a simplified and efficient method to obtain autologous PL to replace animal serum in cell culture applications is described. STUDY DESIGN AND METHODS: PL obtained by freezing and centrifugation procedures was tested as medium supplement for human adipose mesenchymal stem cell (hASC) culture. Differential proliferation, immunophenotypic changes, and differentiation under PL or fetal bovine serum (FBS) were assessed. RESULTS: In contrast to 10% FBS supplementation, cell population doubling time was significantly lower when hASCs were cultured with the same concentration of PL ( PL 22.9 +/- 1.5 hr vs. FBS 106.7 +/- 6.5 hr, t test, p < 0.05). Furthermore, hASCs maintained with 2.5% PL supplementation also showed satisfactory results. Immunophenotypic analysis revealed no differences between hASCs cultivated with PL or FBS supplementation and both cultures retained the potential to differentiate into adipose cells. These results demonstrate that autologous PL obtained from the same donor can be used as animal serum substitute in hASC culture. CONCLUSIONS: Taken together, evidence is provided that platelets provided by a single donor are sufficient to obtain PL for hASC propagation for clinical-scale applications mitigating the potential untoward side effects associated with the use of animal-derived reagents.
引用
收藏
页码:2680 / 2685
页数:6
相关论文
共 20 条
[1]
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fetal calf serum substitute [J].
Bernardo, M. E. ;
Avanzini, M. A. ;
Perotti, C. ;
Cometa, A. M. ;
Moretta, A. ;
Lenta, E. ;
Del Fante, C. ;
Novara, F. ;
De Silvestri, A. ;
Amendola, G. ;
Zuffardi, O. ;
Maccario, R. ;
Locatelli, F. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (01) :121-130
[2]
Black LL, 2007, VET THER, V8, P272
[3]
A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis [J].
Chapman, William C. ;
Singla, Neil ;
Genyk, Yuri ;
McNeil, James W. ;
Renkens, Kenneth L., Jr. ;
Reynolds, Thomas C. ;
Murphy, Aileen ;
Weaver, Fred A. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (02) :252-265
[4]
Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications [J].
Doucet, C ;
Ernou, I ;
Zhang, YZ ;
Llense, JR ;
Begot, L ;
Holy, X ;
Lataillade, JJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (02) :228-236
[5]
Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children [J].
Fang, Baijun ;
Song, Yongping ;
Lin, Quande ;
Zhang, Yanli ;
Cao, Ying ;
Zhao, Robert Chunhua ;
Ma, Yuanfang .
PEDIATRIC TRANSPLANTATION, 2007, 11 (07) :814-817
[6]
A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation [J].
García-Olmo, D ;
García-Arranz, M ;
Herreros, D ;
Pascual, I ;
Peiro, C ;
Rodríguez-Montes, JA .
DISEASES OF THE COLON & RECTUM, 2005, 48 (07) :1416-1423
[7]
Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease:: a new cell-based therapy [J].
García-Olmo, D ;
García-Arranz, M ;
García, LG ;
Cuellar, ES ;
Blanco, IF ;
Prianes, LA ;
Montes, JAR ;
Pinto, FL ;
Marcos, DH ;
García-Sancho, L .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2003, 18 (05) :451-454
[8]
Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula: a Phase II Clinical Trial [J].
Garcia-Olmo, Damian ;
Herreros, Dolores ;
Pascual, Isabel ;
Antonio Pascual, Jose ;
Del-Valle, Emilio ;
Zorrilla, Jaime ;
De-La-Quintana, Paloma ;
Garcia-Arranz, Mariano ;
Pascual, Maria .
DISEASES OF THE COLON & RECTUM, 2009, 52 (01) :79-86
[9]
Preclinical safety of recombinant human thrombin [J].
Heffernan, Jane K. ;
Ponce, Rafael A. ;
Zuckerman, Linda A. ;
Volpone, John P. ;
Visich, Jennifer ;
Giste, Erika E. ;
Jenkins, Nancy ;
Boster, Dan ;
Pederson, Susan ;
Knitter, Glenn ;
Palmer, Thomas ;
Wills, Margaret ;
Early, Richard J. ;
Rogge, Mark C. .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2007, 47 (01) :48-58
[10]
Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase [J].
Jaiswal, RK ;
Jaiswal, N ;
Bruder, SP ;
Mbalaviele, G ;
Marshak, DR ;
Pittenger, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (13) :9645-9652